159 related articles for article (PubMed ID: 11559352)
1. The H89 cAMP-dependent protein kinase inhibitor blocks Plasmodium falciparum development in infected erythrocytes.
Syin C; Parzy D; Traincard F; Boccaccio I; Joshi MB; Lin DT; Yang XM; Assemat K; Doerig C; Langsley G
Eur J Biochem; 2001 Sep; 268(18):4842-9. PubMed ID: 11559352
[TBL] [Abstract][Full Text] [Related]
2. Protein Kinase A Is Essential for Invasion of Plasmodium falciparum into Human Erythrocytes.
Wilde ML; Triglia T; Marapana D; Thompson JK; Kouzmitchev AA; Bullen HE; Gilson PR; Cowman AF; Tonkin CJ
mBio; 2019 Oct; 10(5):. PubMed ID: 31594816
[TBL] [Abstract][Full Text] [Related]
3. Characterization of an A-kinase anchoring protein-like suggests an alternative way of PKA anchoring in Plasmodium falciparum.
Bandje K; Naissant B; Bigey P; Lohezic M; Vayssières M; Blaud M; Kermasson L; Lopez-Rubio JJ; Langsley G; Lavazec C; Deloron P; Merckx A
Malar J; 2016 Apr; 15():248. PubMed ID: 27129434
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of Plasmodium falciparum cyclic AMP-dependent protein kinase and its mammalian homologue to the inhibitors.
Sudo A; Kato K; Kobayashi K; Tohya Y; Akashi H
Mol Biochem Parasitol; 2008 Aug; 160(2):138-42. PubMed ID: 18501980
[TBL] [Abstract][Full Text] [Related]
5. Antimalarial activity of novel 4-cyano-3-methylisoquinoline inhibitors against Plasmodium falciparum: design, synthesis and biological evaluation.
Buskes MJ; Harvey KL; Richards BJ; Kalhor R; Christoff RM; Gardhi CK; Littler DR; Cope ED; Prinz B; Weiss GE; O'Brien NJ; Crabb BS; Deady LW; Gilson PR; Abbott BM
Org Biomol Chem; 2016 May; 14(20):4617-39. PubMed ID: 27105169
[TBL] [Abstract][Full Text] [Related]
6. Expression and biochemical characterization of the Plasmodium falciparum protein kinase A catalytic subunit.
Wurtz N; Pastorino B; Almeras L; Briolant S; Villard C; Parzy D
Parasitol Res; 2009 Jun; 104(6):1299-305. PubMed ID: 19159956
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Plasmodium falciparum cyclic-adenosine monophosphate (cAMP)-dependent protein kinase (PfPKA) as a therapeutic target.
Haste NM; Talabani H; Doo A; Merckx A; Langsley G; Taylor SS
Microbes Infect; 2012 Aug; 14(10):838-50. PubMed ID: 22626931
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium falciparum regulatory subunit of cAMP-dependent PKA and anion channel conductance.
Merckx A; Nivez MP; Bouyer G; Alano P; Langsley G; Deitsch K; Thomas S; Doerig C; Egée S
PLoS Pathog; 2008 Feb; 4(2):e19. PubMed ID: 18248092
[TBL] [Abstract][Full Text] [Related]
9. Exploration of 3-methylisoquinoline-4-carbonitriles as protein kinase A inhibitors of Plasmodium falciparum.
Buskes MJ; Harvey KL; Prinz B; Crabb BS; Gilson PR; Wilson DJD; Abbott BM
Bioorg Med Chem; 2016 Jun; 24(11):2389-2396. PubMed ID: 27112453
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP and calcium interplay as second messengers in melatonin-dependent regulation of Plasmodium falciparum cell cycle.
Beraldo FH; Almeida FM; da Silva AM; Garcia CR
J Cell Biol; 2005 Aug; 170(4):551-7. PubMed ID: 16103224
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.
Diaz CA; Allocco J; Powles MA; Yeung L; Donald RG; Anderson JW; Liberator PA
Mol Biochem Parasitol; 2006 Mar; 146(1):78-88. PubMed ID: 16325279
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase beta is the master regulator of cAMP signalling during malaria parasite invasion.
Flueck C; Drought LG; Jones A; Patel A; Perrin AJ; Walker EM; Nofal SD; Snijders AP; Blackman MJ; Baker DA
PLoS Biol; 2019 Feb; 17(2):e3000154. PubMed ID: 30794532
[TBL] [Abstract][Full Text] [Related]
13. PfCDPK1 mediated signaling in erythrocytic stages of Plasmodium falciparum.
Kumar S; Kumar M; Ekka R; Dvorin JD; Paul AS; Madugundu AK; Gilberger T; Gowda H; Duraisingh MT; Keshava Prasad TS; Sharma P
Nat Commun; 2017 Jul; 8(1):63. PubMed ID: 28680058
[TBL] [Abstract][Full Text] [Related]
14. The 3-phosphoinositide-dependent protein kinase 1 is an essential upstream activator of protein kinase A in malaria parasites.
Hitz E; Wiedemar N; Passecker A; Graça BAS; Scheurer C; Wittlin S; Brancucci NMB; Vakonakis I; Mäser P; Voss TS
PLoS Biol; 2021 Dec; 19(12):e3001483. PubMed ID: 34879056
[TBL] [Abstract][Full Text] [Related]
15. PfPK7, an atypical MEK-related protein kinase, reflects the absence of classical three-component MAPK pathways in the human malaria parasite Plasmodium falciparum.
Dorin D; Semblat JP; Poullet P; Alano P; Goldring JP; Whittle C; Patterson S; Chakrabarti D; Doerig C
Mol Microbiol; 2005 Jan; 55(1):184-96. PubMed ID: 15612927
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterisation of a cAMP-dependent protein kinase catalytic subunit gene from Plasmodium falciparum.
Li J; Cox LS
Mol Biochem Parasitol; 2000 Jul; 109(2):157-63. PubMed ID: 10960174
[No Abstract] [Full Text] [Related]
17. cAMP-dependent protein kinase from Plasmodium falciparum: an update.
Wurtz N; Chapus C; Desplans J; Parzy D
Parasitology; 2011 Jan; 138(1):1-25. PubMed ID: 20663247
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Plasmodium falciparum CDP-diacylglycerol synthase, a proteolytically cleaved enzyme.
Martin D; Gannoun-Zaki L; Bonnefoy S; Eldin P; Wengelnik K; Vial H
Mol Biochem Parasitol; 2000 Sep; 110(1):93-105. PubMed ID: 10989148
[TBL] [Abstract][Full Text] [Related]
19. Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes.
Naughton JA; Nasizadeh S; Bell A
Mol Biochem Parasitol; 2010 Oct; 173(2):81-7. PubMed ID: 20478341
[TBL] [Abstract][Full Text] [Related]
20. The Stapled AKAP Disruptor Peptide STAD-2 Displays Antimalarial Activity through a PKA-Independent Mechanism.
Flaherty BR; Wang Y; Trope EC; Ho TG; Muralidharan V; Kennedy EJ; Peterson DS
PLoS One; 2015; 10(5):e0129239. PubMed ID: 26010880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
